Here, we observe that the highest activation status of CD3+CD56+CD8+ cells occurred at the third trimester of gestation, when sex hormones reach their peak, and thereby would coincide with the reported strongest decrease in relapse rate in MS patients (34). This evidence concerns the gene CD8A and myeloid sarcoma.